Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,232.00    -24.00 (-1.91%)
Bid:
1,232.00
Ask:
1,242.00
Spread: 10.00 (0.812%)
Market Cap: £564.58m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

AGM Statement

16 Sep 2014 07:00

RNS Number : 7423R
Cohort PLC
16 September 2014
 



16 September 2014

 

COHORT PLC ("Cohort")

AGM Statement & First Quarter Update

 

Cohort, the independent technology group, is today holding its Annual General Meeting. The Chairman, Nick Prest, will make the following remarks to the meeting:

 

"Cohort again improved its performance last year, achieving an 11% increase in adjusted operating profit to £8.2m. Both SCS and SEA strongly improved their performance with MASS remaining the largest contributor to the Group's profitability. At the year end, net funds were £16.3m. The Group's order book remained strong at £82m, with around 58% of externally forecast 2014/15 revenue underpinned by customer orders a similar percentage to last year.

"In line with our stated strategy, on 9th July 2014 we acquired a controlling interest in Marlborough Communications Limited (MCL), a supplier of advanced electronic communications and surveillance technology, for an initial cash consideration of £6.0m. As indicated at the time, this acquisition strengthens and broadens the Group's portfolio and is expected to be immediately earnings enhancing. We see a number of further opportunities to acquire complementary businesses.

"We have continued to improve our order book position in the early months of the current financial year and the Group's order book has increased to £89m as at 31st August including the £5.4m acquired with the MCL business.

"In aggregate, these orders have improved our revenue visibility for the current year. Beyond these successes we continue to see good domestic and export opportunities, though the timing of the latter is always hard to predict.

 "As expected, the Group's year end peak working capital has mostly unwound in the first few months of this year and the Group cash at 31st August stood at over £14m after payment of the £6.0m initial consideration for the MCL transaction.

"Overall, Cohort's trading, order intake and prospects at this early stage of the year are consistent with making further progress in 2014/15".

Ends

 

For further information please contact:

Cohort plc

0118 909 0390

Andy Thomis, Chief Executive

 

Simon Walther, Finance Director

 

Investec Bank Plc

020 7597 5970

Keith Anderson / Daniel Adams

 

MHP Communications Limited

020 3128 8100

Reg Hoare / Vicky Watkins

 

 

NOTES TO EDITORS

Cohort plc

Cohort is an independent technology group working primarily for defence (air, land and sea), wider government and industry clients, through four market-facing subsidiary companies:

MASS - a specialist systems house with considerable experience in the defence market and a focus on electronic warfare operational support and secure information systems. Based in Cambridgeshire, MASS was acquired by Cohort in August 2006;

MCL - an expert in electronic and surveillance technology design and manufacturing, product and in the field support and training for a range of specialist UK end users, including the MOD and other governmental agencies. Based in Surrey, MCL has been part of the Group since July 2014;

SCS - a defence technical advisory business, combining technical expertise with practical experience and domain knowledge. Owned by Cohort since flotation in March 2006;

SEA - an advanced surveillance systems and software house with hardware development capability operating in the defence and transport market sectors. Acquired by Cohort in October 2007.

Cohort was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 500 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Lincolnshire, Somerset and Surrey.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSFFFWIFLSESU
Date   Source Headline
1st Jun 202611:41 amRNSTotal Voting Rights
27th May 20267:00 amRNSFull Year Trading Update
26th May 20267:00 amRNSNotice of Full Year Trading Update
12th May 202610:46 amRNSHolding(s) in Company
1st May 20269:37 amRNSTotal Voting Rights
10th Apr 20263:58 pmRNSDirector/PDMR Shareholding
10th Apr 202612:35 pmRNSHolding(s) in Company
2nd Apr 20267:00 amRNSBlock Listing Six Monthly Return
1st Apr 202610:10 amRNSTotal Voting Rights
26th Mar 20267:00 amRNSContract Announcement
23rd Mar 20267:00 amRNSContract Announcement
2nd Mar 202611:57 amRNSTotal Voting Rights
25th Feb 20269:51 amRNSBlock Listing Six Monthly Return
20th Feb 20267:00 amRNSDirector/PDMR Shareholding
17th Feb 20263:41 pmRNSHolding(s) in Company
16th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20269:35 amRNSHolding(s) in Company
2nd Feb 20264:54 pmRNSTotal Voting Rights
30th Jan 20267:00 amRNSContract Wins
20th Jan 202612:40 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSInterim Report 2025
5th Jan 20269:00 amRNS-RInvestor Presentation via Equity Development
2nd Jan 202612:40 pmRNSTotal Voting Rights
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
15th Dec 202511:56 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:01 amRNSHalf Year Results
1st Dec 202512:20 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSNotice of Half Year Results
4th Nov 202511:59 amRNSTotal Voting Rights
27th Oct 20254:37 pmRNSDirector/PDMR Shareholding
16th Oct 202510:11 amRNSDirector/PDMR Shareholding
7th Oct 20253:15 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSMASS secures £15.7m countermeasures contract
2nd Oct 202511:03 amRNSBlock Listing Six Monthly Return
1st Oct 20259:53 amRNSTotal Voting Rights
25th Sep 20254:59 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Statement
19th Sep 20255:12 pmRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNS-RInvestor Presentation
10th Sep 20253:21 pmRNSDirector/PDMR Shareholding
3rd Sep 202510:57 amRNSDirector/PDMR Shareholding
1st Sep 202511:05 amRNSTotal Voting Rights
26th Aug 20253:22 pmRNSBlock Listing Six Monthly Return
20th Aug 20253:56 pmRNSAnnual Report and Notice of Annual General Meeting
15th Aug 20253:35 pmRNSDirector/PDMR Shareholding
11th Aug 20255:10 pmRNSDirector/PDMR Shareholding
1st Aug 20254:16 pmRNSTotal Voting Rights
17th Jul 20259:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.